tykhr
sign in
free sign up
Inhibrx Biosciences, Inc.
Biotechnology
Healthcare
INBX
15.47 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
27.12
52 week high
29.59
high
29.07
52 week low
0.00
low
27.12
growth
77.52 %
previous Close
27.12
P/E ratio
-16
market cap
220 M
div yield
0
usd
Jun 2025
qoq
revenue
1.30 M
0.00 %
net incoming
-28.65 M
33.84 %
eps
-1.85 %
33.84 %
eps surprise
0.00 %
net profit margin
-2204.15 %
-2204.00 %
operating incoming
-27.39 M
36.16 %
net change in cash
-29.95 M
-146.86 %
cash on hand
187 M
-13.83 %
cost of revenue
0.00 %
top